Pediatric (BP, weight conversion) Information

Transcription

1 Pediatric (BP, weight conversion) Information Reference Reviewed: Updated: Blood pressure Minimal systolic BP = 70 + (2 x age) Normal systolic BP = 90 + (2 x age) Estimation of Pediatric Weight (2 x age) + 8 = weight in (kilograms) Weight in pounds 2.2 = weight in (kilograms) Weight in kilograms x 2.2 = weight in lbs (pounds) Pediatric Endotracheal Tube Size ETT size (age/4)

2 General: Universal Patient Care/Initial Patient Care Protocol Reviewed: Updated: 15 History Physical Differential Diagnoses PEARL/S: Complete vital signs should be taken every five (5) minutes for critical patients and every 15 minutes for non-critical patients. Complete vital signs include a minimum of heart/pulse rate, respiratory rate and blood pressure. In most cases on-scene times should be limited to ten (10) minutes. Do not delay oxygen therapy to obtain pulse oximetry reading. All patients that refuse transport must have documented vital signs and the refusal must be signed. Scene safety/personal protective equipment Primary Assessment with initial interventions as needed. Supplemental O2 (see Oxygen Administration Guideline); capnography as indicated Obtain and document: Vital signs SAMPLE history Pain assessment OPQRST (medical) DCAP-BTLS (trauma) Consider glucometry if indicated Cardiac monitor/12-lead ECG as indicated. Appropriate protocol/consider differential diagnoses. If no protocol applies or condition is unknown consult medical command. Transport per guidelines.

3 Patient Hand-off Information Reference Reviewed: 15 Updated: 15 Essential Elements of Information Patient s name Age Chief complaint History Vital signs o Last set taken Assessment Treatment/s Transport impact o Any changes in the patient s condition enroute Do you have any questions for me

4 Pediatric: Medical Abdominal Pain Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Pain Tenderness Nausea/vomiting Dysuria/hematuria Vaginal bleeding/discharge Fever Headache Malaise Location of pain Age Past medical/surgical history Medications Onset Provocation/Palliation Radiation Severity Time Fever Last oral intake Last bowel movement/emesis Menstrual history Diarrhea Constipation PEARL/S: Keep NPO (nothing by mouth), other than oral medications. Trauma Pregnancy Pneumonia Pulmonary embolism Liver disease Peptic ulcer disease Gastritis Gallbladder Myocardial infarction Pancreatitis Kidney stone Abdominal aneurysm Appendicitis Bladder/prostate Pelvic inflammatory Ovarian cyst Spleen enlargement Diverticulitis Bowel obstruction Gastroenteritis

5 Pediatric: Medical Abdominal Pain TJEMS EN/A Med Control Universal Care Protocol Nausea and vomiting, consider ondansetron (Zofran ) 4mg, ODT (orally disintegrating tablet). IV/IO/Vascular Access Nausea and vomiting, consider ondansetron (Zofran ) 4mg IV, may repeat in 10 minutes Fentanyl (Sublimaze ) Pediatrics (2 year old and greater): 1 microgram/ IV/IO/IM, may be repeated once in 10 minutes Maximum single dose is 50 micrograms 2 micrograms/ IN, half of dose in each nostril, may be repeated once in 10 minutes Maximum single dose is 50 micrograms. Consider administration of ondansetron (Zofran ) to patients with significant pain who will receive narcotic pain medications and are already nauseated or at risk for nausea/vomiting. Children (4 years old and greater): 4 mg ODT (orally disintegrated tablet), may be repeated once in 10 minutes 4mg IV/IO/IM, may be repeated once in 10 minutes Pediatrics (less than 4 years old): 2 4 mg orally or IV/IO/IM Observe patient carefully for any signs of respiratory depression or changes in vital signs when administering pain medications. Medication Name Fentanyl (Sublimaze) Ondansetron (Zofran) Medication Dose Newborn 10 1 mcg/ mg/

6 Pediatric: Medical Allergic Reaction/Anaphylaxis Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Onset and location Insect bite or sting Food allergy/exposure New clothing, soap or detergent Past history of reactions Past medical history Medication history Medication allergy/exposure Is this a reaction that your physician advised you to use the epi-pen? Itching or hives Coughing or wheezing Chest or throat constriction Difficulty swallowing Hypotension/shock Edema Vomiting Rash only Anaphylaxis Shock Angioedema Aspiration/airway obstruction Asthma PEARL/S: Any patient receiving epinephrine must be transported. IM injection is preferred in the anterior lateral thigh. EN/A Allergic reaction Universal Care Protocol with an emphasis on adequate oxygenation. Remove from source of exposure, if safe. Diphenhydramine (Benadryl ); 1 mg//im (in thigh) (maximum 50 mg) Anaphylaxis Universal Care Protocol with an emphasis on adequate oxygenation. Remove from source of exposure, if safe. Administer or assist patient with their own Epi-Pen Jr. (Epi-Pen if greater than /66 lbs) for respiratory distress, inadequate perfusion or severe hives 1. Epinephrine 1:1,000; 0.01 mg/ IM (in thigh) (maximum 0.3 mg), may repeat in 10 minutes. 2. Albuterol sulfate 2.5 mg; nebulized for wheezing/bronchospasm EN/A 3. IV/IO/Vascular Access 4. Diphenhydramine (Benadryl ); 1 mg//iv (maximum 50 mg), or IM (in thigh) 5. Methylprednisolone (Solu-Medrol ); 1 mg/ IV over 1 minute Med Consider additional doses of epinephrine. Control Medication Name Medication Dose Newborn Diphenhydramine (Benadryl) 1 mg/ Epi 1:1,000 (Adrenalin) 0.01 mg/ Methylprednisolone (Solu-Medrol) 1 mg/

7

8 Pediatric: Medical Altered Mental Status Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Altered mental status Sleepiness Incontinence Observed seizure activity Evidence of trauma Unconsciousness Reported/witnessed seizure activity Previous seizure history Medic alert information Seizure medications History of trauma History of diabetes History of pregnancy Head trauma Tumor Metabolic, hepatic or renal failure Hypoxia Electrolyte imbalance Medication non-compliance Infection/Fever Alcohol withdrawal Eclampsia Stroke Hyperthermia Hypoglycemia PEARL/S: Poison control cannot act as medical command, contact for advise only. Do not use patient s glucometer. EN/A Universal Care Protocol with an emphasis on adequate oxygenation IV/IO/Vascular Access Administer glucose: Children > 8 years of age: Dextrose 50% 1 /, IV or IO Children 2 to 8 years of age: Dextrose 25% 2 / IV or IO Children 1 month to 2 years: Dextrose 12.5% 4 / IV or IO Newborn: Dextrose 12.5% 2 / IV or IO Glucagon 1 mg IM Naloxone (Narcan ) 0.1 mg/ IV, IO or IM for suspected narcotic overdose with respiratory depression. Maximum 2 mg

9 Dextrose Pediatric Mixing Chart Mililiters D12.5 D12.5 D12.5 D12.5 D25 D25 D25 D25 D25 D25 D50 D50 to draw up NS to draw up Total ml to give

10 Pediatric: Medical Newborn Resuscitation Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Apneic Central cyanosis Unresponsive Bradycardia Pulseless Due date and gestational age Multiple gestation Meconium Delivery difficulties Congenital disease Maternal medications Maternal risk factor (substance abuse) Airway failure (secretions/respiratory drive) Infection Maternal medication effect Hypovolemia Hypoglycemia Congenital heart process Hypothermia PEARL/S: IV fluids should be administered over less than minutes. IO access should be attempted if no peripheral access in 2 attempts or 90 seconds.

11 Pediatric: Medical Newborn Resuscitation EN/A I/P Universal Care Protocol with an emphasis on adequate oxygenation Assess ABC s using base of umbilical cord, brachial or femoral artery, or auscultation of heart sounds. Place newborn on back with neck in neutral position Suction mouth prior to nose. Not any meconium presence. After delivery, use mild stimulation (dry, warm, suction). If effective respirations are not present after 5 10 seconds of stimulation, BVM at breaths/minute. If heart rate is < 60 bpm with no improvement after BVM for seconds, begin CPR. Dry the newborn, wrap in blanket, head cap to maintain warmth, place baby against your skin. Do not allow newborn to become hypothermic. Record APGAR score at 1 and 5 minutes. Evaluate or treat for hypoglycemia. Dextrose 12.5% 2 / IV or IO IO if required for medication or fluid (10 / bolus may repeat) administration. Follow specific algorithms for bradycardia, tachycardia or cardiac arrest

12 Pediatric: Medical Overdose/Poisoning/Toxic Ingestion Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Mental status change Hypotension/Hypertension Decrease respiratory rate Tachycardia Dysrhythmias Seizures Behavioral changes Ingestion of toxic substance Route and quantity of ingestion Time of ingestion Reason (suicide/accidental) Available medications near patient Past medical history Tricyclic anti-depressants Acetaminophen Depressants Stimulants Anti-cholinergic Cardiac medications Solvents, cleaning agents Insecticides (organophosphates) Aspirin Smoke inhalation PEARL/S: Intubated patients should not receive naloxone (Narcan ) unless hemodynamically unstable. Tachycardia is not a contraindication to atropine administration. Air medical resources will not transport contaminated patients. If questions about the drug or poison involved, consider Poison Control consultation DO NOT DELAY TRANSPORT!!!

13 Pediatric: Medical Overdose/Poisoning/Toxic Ingestion TJEMS EN/A I/P Universal Care Protocol with an emphasis on adequate oxygenation Identify substance and assure decontamination. Flush skin/membrane with appropriate solution if indicated. Overdose Naloxone (Narcan ); 2 mg IN, 1 mg/ in each nostril. IV/IO/Vascular Access Naloxone (Narcan ); 0.1 mg/ IV or IM, for suspected narcotic overdose. Maximum of 2 mg. Diphenhydramine (Benadryl ); 1 mg/ slow IV or IM for dystonic reaction. Maximum dose of 50 mg. For symptomatic Tricyclic Anti-depressant Overdose: (if QRS > 0.12 seconds, hypotension or dysrhythmia). Sodium bicarbonate 1 meq/ slow IV push over 2 minutes. For symptomatic Calcium Channel Blocker Overdose: (if bradycardic, QRS > 0.12 seconds, heart block, hypotension, lethargy, slurred speech, nausea/vomiting). Calcium chloride; 10 mg/ slow IV push over 10 minutes. For symptomatic Organophosphate Poisoning: (secretions, bronchospasm, seizures, bradycardia) Atropine sulfate; 0.05 mg/ IV, doubled every 5 10 minutes until decreased secretions. Medication Name Medication Dose Newborn Atropine sulfate 0.02 mg/ 2 Calcium 10 mg/ 1 chloride Diphenhydra 1 mg/ 0.2 mine (Benadryl) Naloxone 0.1 mg/ (Narcan) Sodium bicarb 1 meq/ NS NS NS NS NS NS + NS

14 History Physical Differential Diagnoses Time of onset Possibility of foreign body Medical history Medications Fever or respiratory infection Sick siblings History or trauma Wheezing or stridor Retractions Increased heart rate Altered LOC Anxious appearance Nasal flaring Delayed capillary refill Excessive drooling Asthma Aspiration Infection (pneumonia, croup) Congenital heart disease Medication or toxin Trauma Airway obstruction PEARL/S: Severely symptomatic is defined as: o Inability to speak normally o Severe wheezing o Absent or diminished breath sounds; and/or o Poor perfusion. In upper airway disorders, invasive airway maneuvers should be avoided if possible. Consider air medical request for prolonged transports. Medication Name Pediatric: Medical Respiratory distress/asthma/copd/croup/reactive airway Medication Dose Protocol Reviewed: 15 Updated: 15 Newborn Epi 1:1,000 (Adrenalin) Methylprednisolone (Solu-Medrol) 0.01 mg/ mg/ TJEMS EN/A I/P Universal Care Protocol with an emphasis on adequate oxygenation. Allow child to assume position of comfort. Assist patient with prescribed Metered Dose Inhaler. Albuterol sulfate 2.5 mg via nebulizer for wheezing and bronchospasm. Albuterol sulfate 2.5 mg and Ipratropium (Atrovent ) 0.5 mg; via nebulizer for bronchospasm. May repeat albuterol sulfate as long as patient is symptomatic. NS 2 3 ; via nebulizer for suspected croup or epiglottitis. IV/IO/Vascular Access Methylprednisolone (Solu-Medro l); 1 mg/ IV, for severe asthma or croup Epinephrine 1:1,000; 2 mg plus 1 NS (total volume of 3 ); nebulized for moderate to severe patients with suspected croup or epiglottitis. Epinephrine 1:1,000; 0.01 mg/ IM, single maximum dose 0.3 mg for severely symptomatic patients. May repeat every minutes for a maximum of 3 doses if still symptomatic.

15 Pediatric: Medical Seizure Protocol Reviewed: 15 Updated: 15 History Physical Differential Diagnoses Observed seizure activity Altered mental status Hot, dry skin Elevated body temperature Fever Prior history of seizure Seizure medications Head trauma Congenital abnormality Fever Infection Head trauma Medication or toxin Hypoxia Hypoglycemia Metabolic abnormality Tumor PEARL/S: For actively seizing patients, initial medications should be administered IM to avoid any delay in care. Medication Name Medication Dose Newborn Midazolam (Versed) 0.1 mg/ EN/A I/P Med Control Universal Care Protocol with an emphasis on adequate oxygenation. Encourage parents to use rectal Valium, if available IV/IO/Vascular Access Administer glucose: Children > 8 years of age: Dextrose 50% 1 /, IV or IO Children 2 to 8 years of age: Dextrose 25% 2 /, IV or IO Children 1 month to 2 years: Dextrose 12.5% 4 /, IV or IO Newborn: Dextrose 12.5% 2 /, IV or IO Glucagon 1 mg IM For patient weight of 13 [28 lbs.] or greater: Midazolam (Versed ); 5 mg IM, if actively seizing. May repeat in 10 minutes for continued seizures. Midazolam (Versed ); 0.1 mg/ IV/IO, maximum single dose of 5 mg. May repeat once in 10 minutes for continued seizures. Contact Medical Command if seizure persists after two (2) doses of benzodiazepine.

16 Dextrose Pediatric Mixing Chart Mililiters D12.5 D12.5 D12.5 D12.5 D25 D25 D25 D25 D25 D25 D50 D50 to draw up NS to draw up Total ml to give

17